Is BAM-15 FDA approved?
No. This profile records BAM-15 as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Metabolic CATEGORY
BAM-15
THE CALORIE BURNER
N5,N6-Bis(2-fluorophenyl)-1,2,5-oxadiazole-3,4-diamine
BAM-15 makes your mitochondria work less efficiently on purpose. This "inefficiency" means your cells burn more calories to produce the same energy. Unlike older uncouplers (like DNP), BAM-15 does this safely without dangerous overheating. The result is increased fat burning, better insulin sensitivity, and improved metabolic health.
BAM-15
BAM-15
BAM-15
BAM-15 Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About BAM-15
What dose does The Peptide App Clinical Team recommend for BAM-15?
Dose: 25-50 mg daily.
MORE CONTEXT ›
Schedule: daily. Cycle: 2-8 weeks on, then assess. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this BAM-15 guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
Mitochondrial Uncoupling
Makes cells burn extra calories by disrupting energy efficiency
Fat Oxidation
Forces the body to burn fat for fuel
Insulin Sensitivity
Improves glucose metabolism and reduces fatty liver
Oxidative Protection
Reduces harmful reactive oxygen species in mitochondria
People struggling with stubborn body fat
Those with fatty liver disease
Anyone wanting to boost resting metabolism
Metabolic syndrome patients
BAM-15 Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES